Trial Profile
Ph II Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head and Neck Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Carboplatin; Fluorouracil; Hydroxycarbamide; Paclitaxel
- Indications Head and neck cancer; Nasopharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 18 May 2020 Status changed from active, no longer recruiting to completed.
- 08 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 08 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2018.